| Revenue growth | FY26 revenue ₹1,713cr, broadly flat to declining YoY. |
|---|---|
| Margins | Q4 EBITDA margin improved to 20.3%; FY26 at 12.9%. |
| Order book | Pharma order book remains intact despite shipment delays. |
| Demand visibility | Improving demand trends in API and CDMO segments for FY27. |
| Management confidence | Confident in recovery post-FDA resolution and inventory normalization. |
Growth
FY26 revenue ₹1,713cr; EBITDA ₹220cr (12.9% margin). Pharma revenue ₹1,021cr; Crop Protection ₹692cr.
Outlook
Targeting 5-6 DMF filings annually. HPAPI plant targeted for FY28. Guidance of ₹500cr Animal Health revenue.
Risks
US FDA warning letter at Bangalore; raw material price spikes in solvents; geopolitical volatility impacting supply.
Earnings Call filed with BSE, NSE: HIKAL. Summary written with AI assistance from the document.
Hikal Ltd: key numbers
- Share price
- ₹225.24
- Market cap
- ₹2,777 Cr
- Revenue (annual)
- ₹1,713 Cr
- Net profit (annual)
- ₹-48.80 Cr
- P/E (TTM)
- -82.2×Sector 47.3×
- Promoter holding
- 68.85%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hikal Ltd
All →Hikal Annual General Meeting
Hikal Ltd held its 38th AGM on September 23, 2026, approving financial statements, director appointments, remuneration revisions, and declaring a total dividend of ₹0.60 per share.
Hikal Production Started
Hikal has begun commercial production at its new cGMP Panoli facility, entering Personal Care manufacturing. First batches of UV filters and skincare ingredients are now being supplied to global customers.
Hikal Other Announcement
Hikal Ltd has filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations, 2015.
Hikal Annual Report
Hikal Limited has submitted its Annual Report for FY 2025-26 and the Notice of its 38th Annual General Meeting to the stock exchanges.
Hikal Annual General Meeting
Hikal Ltd has scheduled its 38th Annual General Meeting for September 23, 2026. The company fixed September 04, 2026, as the record date for final dividend eligibility.
Hikal Management Change
Hikal Limited has appointed Mr. Sameer Hiremath as Chairman and Managing Director for five years. The appointment is effective from October 1, 2026, subject to shareholder approval.
- Execution
- 5 years